Octant Biotech
CA - EmeryvilleBiotechnology
Focus: Octant Biotech is a public small-molecule biotechnology company headquartered in Emeryville, CA, focused on ophthalmology therapeutics. With 501-1000 employees, it operates as a mid-cap biotech player in the specialty pharma segment.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
501-1000
Open Jobs
1
Should You Work at Octant Biotech?
AI assessmentOctant represents a speculative opportunity for ophthalmology specialists willing to take execution risk in a lean, publicly-traded biotech with undisclosed clinical progress.
Why Work Here
- Public company status provides stability, equity upside potential, and access to capital markets for R&D investment
- Focused ophthalmology portfolio allows for deep therapeutic expertise and potential for meaningful clinical impact in a specialized field
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Open Jobs (1)
Interview Prep Quick Facts
Help build intelligence for Octant Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.